18 March 2019 – MGI presented at the 3rd Annual Nordic Precision Medicine Forum, joining the breakout session “A New Era of ‘Broadband’ Sequencing to Realise the Full Benefits of Genomic Information”. The session highlighted the performance and expanding adoption of MGI’s sequencing technologies.
During the event, MGI officially launched its Global Sequencer User Program in Europe, aimed at supporting researchers with access to sequencing platforms, reagents, training and application expertise. The initiative reflects MGI’s commitment to building an open and accessible sequencing ecosystem across the region.
MGI also showcased its MGISEQ-T7 ultra-high-throughput sequencer, capable of delivering up to 6 Tb of data per day, alongside its single-tube long fragment read (stLFR) technology. The stLFR approach enables long-range genomic information using short-read sequencing through DNA co-barcoding, improving the accuracy and efficiency of whole genome analysis while reducing costs.
Speakers from leading European institutions, including the Royal Institute of Technology in Sweden and the University of Helsinki, shared their experience using MGI platforms and highlighted the quality and reliability of the data generated.
The European sequencing market continues to expand rapidly, and MGI’s technologies and user programme aim to provide researchers with a competitive and flexible alternative for high-throughput genomic applications.
